• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tau淀粉样生成六肽AcPHF6*和AcPHF6中基于残基的聚集倾向

Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6.

作者信息

Dangi Abha, Balmik Abhishek Ankur, Ghorpade Archana Kisan, Gorantla Nalini Vijay, Sonawane Shweta Kishor, Chinnathambi Subashchandrabose, Marelli Udaya Kiran

机构信息

Central NMR Facility, CSIR-National Chemical Laboratory Dr HomiBhabha Road 411008 Pune India.

Division of Organic Chemistry, CSIR-National Chemical Laboratory Dr HomiBhabha Road 411008 Pune India.

出版信息

RSC Adv. 2020 Jul 21;10(46):27331-27335. doi: 10.1039/d0ra03809a.

DOI:10.1039/d0ra03809a
PMID:35516938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9055513/
Abstract

In Alzheimer's disease and related tauopathies, the aggregation of microtubule-associated protein, Tau, into fibrils occurs the interaction of two hexapeptide motifs PHF* VQIINK and PHF VQIVYK as β-sheets. To understand the role of the constituent amino acids of PHF and PHF* in the aggregation, a set of 12 alanine mutant peptides was synthesized by replacing each amino acid in PHF and PHF* with alanine and they were characterized by nuclear magnetic resonance (NMR) spectroscopy, circular dichroism (CD), transmission electron microscopy (TEM) and ThS/ANS fluorescence assay. Our studies show that while the aggregation was suppressed in most of the alanine mutant peptides, replacement of glutamine by alanine in both PHF and PHF* enhanced the fibrillization.

摘要

在阿尔茨海默病及相关的tau蛋白病中,微管相关蛋白Tau会聚集成原纤维,这是由两个六肽基序PHFVQIINK和PHF VQIVYK作为β折叠相互作用导致的。为了了解PHF和PHF中组成氨基酸在聚集过程中的作用,通过将PHF和PHF中的每个氨基酸替换为丙氨酸,合成了一组12种丙氨酸突变肽,并通过核磁共振(NMR)光谱、圆二色性(CD)、透射电子显微镜(TEM)和硫黄素T/8-苯胺基-1-萘磺酸(ThS/ANS)荧光测定对它们进行了表征。我们的研究表明,虽然大多数丙氨酸突变肽的聚集受到抑制,但在PHF和PHF中用丙氨酸替换谷氨酰胺会增强纤维化。

相似文献

1
Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6.Tau淀粉样生成六肽AcPHF6*和AcPHF6中基于残基的聚集倾向
RSC Adv. 2020 Jul 21;10(46):27331-27335. doi: 10.1039/d0ra03809a.
2
Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation.二级成核序列影响 tau 聚集的动力学和热力学。
Biochemistry. 2011 Dec 20;50(50):10876-86. doi: 10.1021/bi2014745. Epub 2011 Nov 29.
3
Macrocyclic peptides derived from AcPHF6* and AcPHF6 to selectively modulate the Tau aggregation.从 AcPHF6*和 AcPHF6 衍生的大环肽,以选择性地调节 Tau 聚集。
Bioorg Chem. 2024 Oct;151:107625. doi: 10.1016/j.bioorg.2024.107625. Epub 2024 Jul 10.
4
CH-π interaction in VQIVYK sequence elucidated by NMR spectroscopy is essential for PHF formation of tau.通过核磁共振波谱学阐明的 VQIVYK 序列中的 CH-π 相互作用对于 tau 的 PHF 形成是必不可少的。
Biopolymers. 2014 May;102(3):288-95. doi: 10.1002/bip.22489.
5
Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure.额颞叶痴呆中tau蛋白的突变通过增强局部β结构促进双螺旋丝的聚集。
J Biol Chem. 2001 Dec 21;276(51):48165-74. doi: 10.1074/jbc.M105196200. Epub 2001 Oct 17.
6
Structure of core domain of fibril-forming PHF/Tau fragments.原纤维形成性PHF/Tau片段核心结构域的结构
Biophys J. 2006 Mar 1;90(5):1774-89. doi: 10.1529/biophysj.105.070136. Epub 2005 Dec 9.
7
Morphology of self-assembled structures formed by short peptides from the amyloidogenic protein tau depends on the solvent in which the peptides are dissolved.由淀粉样蛋白tau的短肽形成的自组装结构的形态取决于溶解这些肽的溶剂。
J Pept Sci. 2009 Oct;15(10):675-84. doi: 10.1002/psc.1172.
8
Tau aggregation is driven by a transition from random coil to beta sheet structure.tau蛋白聚集是由从无规卷曲到β折叠结构的转变所驱动的。
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):158-66. doi: 10.1016/j.bbadis.2004.09.010. Epub 2004 Nov 12.
9
Tau Derived Hexapeptide AcPHF6 Promotes Beta-Amyloid (Aβ) Fibrillogenesis.六肽 AcPHF6 促进β-淀粉样蛋白(Aβ)纤维形成。
ACS Chem Neurosci. 2018 Apr 18;9(4):773-782. doi: 10.1021/acschemneuro.7b00433. Epub 2017 Dec 27.
10
Correction: Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6.更正:Tau淀粉样六肽AcPHF6*和AcPHF6中基于残基的聚集倾向。
RSC Adv. 2022 Jun 8;12(27):17049. doi: 10.1039/d2ra90058k. eCollection 2022 Jun 7.

引用本文的文献

1
Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates.新型超敏免疫分析法用于 tau 寡聚体及其相关可溶性聚集物的选择性定量检测
Alzheimers Dement. 2024 Apr;20(4):2894-2905. doi: 10.1002/alz.13711. Epub 2024 Mar 23.
2
The role of wild-type tau in Alzheimer's disease and related tauopathies.野生型tau蛋白在阿尔茨海默病及相关tau蛋白病中的作用。
J Life Sci (Westlake Village). 2020 Dec;2(4):1-17. doi: 10.36069/jols/20201201.

本文引用的文献

1
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.神经退行性疾病中的蛋白质错误折叠、聚集和构象应变。
Nat Neurosci. 2018 Oct;21(10):1332-1340. doi: 10.1038/s41593-018-0235-9. Epub 2018 Sep 24.
2
Structures of filaments from Pick's disease reveal a novel tau protein fold.Pick 病纤维结构揭示了一种新型的 tau 蛋白折叠。
Nature. 2018 Sep;561(7721):137-140. doi: 10.1038/s41586-018-0454-y. Epub 2018 Aug 29.
3
Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic d,l-α-peptide conformational inhibitor.
通过自组装的环状 d,l-α-肽构象抑制剂抑制tau 衍生六肽聚集和毒性。
Chem Commun (Camb). 2018 Jun 8;54(47):5980-5983. doi: 10.1039/c8cc01233d.
4
Structure-based inhibitors of tau aggregation.基于结构的tau 聚集抑制剂。
Nat Chem. 2018 Feb;10(2):170-176. doi: 10.1038/nchem.2889. Epub 2017 Nov 20.
5
Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.萘醌-色氨酸杂合体对重塑 Tau 衍生 PHF6 肽原纤维的作用机制研究。
Sci Rep. 2018 Jan 8;8(1):71. doi: 10.1038/s41598-017-18443-2.
6
Tau-based therapies in neurodegeneration: opportunities and challenges.基于 Tau 的神经退行性变治疗:机遇与挑战。
Nat Rev Drug Discov. 2017 Dec;16(12):863-883. doi: 10.1038/nrd.2017.155. Epub 2017 Oct 6.
7
Cryo-EM structures of tau filaments from Alzheimer's disease.阿尔茨海默病tau蛋白细丝的冷冻电镜结构
Nature. 2017 Jul 13;547(7662):185-190. doi: 10.1038/nature23002. Epub 2017 Jul 5.
8
Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues.tau 蛋白最小淀粉样肽段聚集和毒性的抑制及其前取代类似物。
Chemistry. 2017 Jul 18;23(40):9618-9624. doi: 10.1002/chem.201701218. Epub 2017 Jun 27.
9
Disaggregation of Amylin Aggregate by Novel Conformationally Restricted Aminobenzoic Acid containing α/β and α/γ Hybrid Peptidomimetics.新型构象受限的含α/β和α/γ混合肽模拟物对胰岛淀粉样多肽聚集物的解聚。
Sci Rep. 2017 Jan 5;7:40095. doi: 10.1038/srep40095.
10
Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.具有治疗阿尔茨海默病潜力的tau结合D-对映体肽的筛选与表征
PLoS One. 2016 Dec 22;11(12):e0167432. doi: 10.1371/journal.pone.0167432. eCollection 2016.